NewAmsterdam’s $200m Public Offering on Nasdaq

NautaDutilh assisted NewAmsterdam with their underwritten offering of ordinary shares and pre-funded warrants on Nasdaq.NewAmsterdam (Nasdaq: NAMS), a late-stage biopharmaceutical company focused on developing transformative therapies…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here